Vanguard Group Reduces $21M in Align Technology, Inc. ($ALGN)

Vanguard Group has trimmed its stake in Align Technology, Inc. (NasdaqGS: ALGN), according to its latest 13F filing with the SEC dated January 29, 2026. The investment firm reduced its position by 121,832 shares, a 1.47% decrease, bringing its total holdings to 8,179,779 shares. The value of this stake is approximately $1.45 billion.

What Changed in Vanguard Group's Align Technology Position

Vanguard Group cut its investment in Align Technology by 121,832 shares, reducing its holdings from 8,301,611 to 8,179,779 shares. This move represents a 1.47% decrease in its position, with the current value of its holdings at about $1.45 billion.

Other Institutional Activity in Align Technology

Several other institutional investors have also adjusted their positions in Align Technology. BlackRock, Inc. trimmed its stake by 70,636 shares, holding 4,289,924 shares valued at $735.4 million. Capital World Investors significantly increased its holdings by 2,581,793 shares, ending with 4,072,296 shares worth approximately $698.1 million. Meanwhile, Capital International Investors reduced its position by 834,019 shares, now holding 3,809,202 shares valued at $653 million. Vanguard Portfolio Management LLC added 3,150,783 shares, resulting in a total of 3,150,783 shares valued at $540.1 million.

Align Technology Stock Snapshot

Shares of Align Technology (NasdaqGS: ALGN) are trading near $177.07. The company boasts a market cap of $12.52 billion and a P/E ratio of 29.43. Align Technology's stock has a 52-week low of $122.00 and a high of $208.31. The 50-day moving average stands at $173.31, while the 200-day moving average is $159.42. The company's beta is 1.671, indicating a higher volatility compared to the market.

Recent Earnings

Align Technology reported revenue of approximately $4.10 billion, reflecting a growth of 6.2%. The company's earnings per share (EPS) is $5.94, with a net margin of 10.5% and a return on equity (ROE) of 10.8%. The next earnings release is scheduled for April 29, 2026.

Insider Buying and Selling at Align Technology, Inc.

Recent insider transactions at Align Technology include buys and sells on May 20, 2026. Kevin Conroy purchased 1,836 shares, while Mojdeh Poul sold 1,745 shares and also bought 1,836 shares. Susan Siegel acquired 1,745 shares, and Raymond Larkin Jr. bought 2,448 shares. Britt Vitalone sold 1,443 shares.

Analysts Set New Price Targets

On April 30, 2026, Evercore ISI Group maintained its 'buy' rating on Align Technology with a $220 price target. Morgan Stanley kept its 'hold' rating with a $188 target on April 24. Piper Sandler, on April 21, reiterated a 'buy' rating, setting a $235 target. Citigroup initiated coverage with a 'buy' rating and a $240 target on April 15. The consensus among analysts is a 'buy' rating, with a mean price target of $209.07 based on 14 opinions.

About Align Technology

Align Technology, Inc., headquartered in Tempe, Arizona, is a leader in the healthcare sector, specializing in medical instruments and supplies. The company is widely known for its Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners. Led by CEO Joseph M. Hogan, Align Technology operates globally, providing innovative products and services to dental professionals and patients worldwide.

Bottom Line

Vanguard Group's decision to trim its stake in Align Technology reflects a slight repositioning in its portfolio. While this 13F filing provides a snapshot of Vanguard's holdings as of the reporting period, it may not represent the firm's current position. Align Technology continues to capture investor interest with its strong market presence and innovative products.